Govt, industry meet to focus on trade margin rationalisation of drugs

The Centre has been mulling on rationalizing drug trade margins for a while now for widely used medicines in an effort to bring down prices

Key issues on drug pricing, including trade margin rationalisation (TMR), are likely to be discussed in the day-long meeting between various central government departments and the industry on May 16.

Industry sources revealed that Union Health Minister Mansukh Mandaviya and officials of pharmaceuticals department (DoP), the National Pharmaceutical Pricing Authority (NPPA), health ministry, and several industry bodies would attend the meeting.

TMR is going to be a major issue for discussion in the meeting, the source added. “Apart from this, issues like implementing ceiling price changes from prospective batches and considering price of one brand in case of multiple brands